Research Article

Determining the Joint Effect of Obesity and Diabetes on All-Cause Mortality and Cardiovascular-Related Mortality following an Ischemic Stroke

Table 2

Baseline characteristics of 20,246 ischemic stroke survivors based on BMI categories and diabetes, the PRoFESS trial.

CharacteristicNo diabetes
All participantsUnderweight/
normal weight
OverweightObese
No. (%)No. (%)No. (%)No. (%)

No. of participants a20246595858812693
No. of participants who died from all causes1485495337126
No. of participants who died from cardiovascular-related causes88728819067
Diabetes
 No14532 (71.78)
 Yes5714 (28.22)
BMI categories
 Underweight/normal weight7864 (38.84)
 Overweight8138 (40.20)
 Obese4244 (20.96)
BMI (kg/m2) (median, IQR)26.1 (23.6-29.3)22.9 (21.3-24.1)27.1 (26.0-28.3)32.5 (31.1-35.2)
Sociodemographic Characteristics
Age
 ≥ 65 years11107 (54.86)3558 (59.72)3288 (55.91)1364 (50.65)
Gender
 Male12976 (64.09)3843 (64.50)4025 (68.44)1450 (53.84)
Race/ethnicity
 White11600 (57.3)2834 (47.57)3972 (67.54)2118 (78.65)
 Black804 (3.97)146 (2.45)177 (3.01)149 (5.53)
 Asian6645 (32.82)2712 (45.52)1416 (24.08)236 (8.76)
 Hispanic987 (4.88)223 (3.74)271 (4.61)148 (5.50)
 Other210 (1.04)43 (0.72)45 (0.77)42 (1.56)
Clinical Characteristics
Qualifying stroke neurological severity
 Mild18896 (93.35)5512 (92.53)5571 (94.76)2555 (94.88)
 Moderate/Severe1347 (6.65)445 (7.47)308 (5.24)138 (5.11)
Qualifying stroke subtype
 Large vessel atherosclerosis5789 (28.61)1851 (31.09)1594 (27.12)639 (23.75)
 Cardioembolic369 (1.82)111 (1.86)126 (2.14)64 (2.38)
 Small vessel disease10530 (52.04)2999 (50.38)2986 (50.80)1399 (52.01)
 Other411 (2.03)109 (1.83)133 (2.26)66 (2.45)
 Unknown3135 (15.49)883 (14.83)1039 (17.68)522 (19.41)
Baseline systolic blood pressure (median, IQR)142 (130-156)141 (130-155)142 (131-156)143 (131-157)
Treatment group
 A †5024 (25.01)1499 (25.36)1464 (25.07)672 (25.17)
 B ‡5004 (24.91)1442 (24.39)1472 (25.21)680 (25.47)
 C §5041 (25.09)1462 (24.73)1461 (25.02)636 (23.82)
 D | |5019 (24.99)1509 (25.52)1442 (24.70)682 (25.54)
Risk Factors and Comorbidities
History of previous stroke or TIA
 Yes4975 (24.58)1482 (24.89)1337 (22.74)602 (22.37)
History of previous myocardial infarction
 Yes1362 (6.73)292 (4.90)382 (6.50)199 (7.39)
History of atrial fibrillation
 Yes538 (2.66)165 (2.77)183 (3.11)89 (3.30)
History of congestive heart failure
 Yes532 (2.63)113 (1.90)143 (2.43)121 (4.49)
History of coronary artery disease
 Yes3296 (16.28)729 (12.24)994 (16.90)534 (19.83)
History of hypertension
 Yes14987 (74.03)3788 (65.58)4264 (72.52)2152 (79.91)
History of hyperlipidemia
 Yes9453 (46.76)2245 (37.73)2730 (46.48)1366 (50.89)
Smoking status
 Current smoker4288 (21.19)1682 (28.24)1217 (20.70)406 (15.09)
Regular alcohol consumption
 ≥ 1 drink/week7206 (35.45)2217 (37.22)2434 (41.39)959 (35.64)
Average physical activity prior to qualifying stroke
 Sedentary7209 (35.83)1824 (30.76)1865 (31.95)1175 (44.01)
 Some physical activity6446 (32.04)1979 (33.37)1937 (33.18)786 (29.44)
 Intense physical activity6465 (32.13)2127 (35.87)2036 (34.87)709 (26.55)

CharacteristicDiabetes
Underweight/
normal weight
OverweightObese
No. (%)No. (%)No. (%)

No. of participants190622571551
No. of participants who died from all causes219180128
No. of participants who died from cardiovascular-related causes13611195
Diabetes
 No
 Yes
BMI categories
 Underweight/normal-weight
 Overweight
 Obese
BMI (kg/m2) (median, IQR)23.0 (21.5-24.0)27.2 (26.0-28.4)33.1 (31.3-36.3)
Sociodemographic Characteristics
Age
 ≥ 65 years1000 (52.47)1178 (52.19)719 (46.36)
Gender
 Male1271 (66.68)1530 (67.79)857 (55.25)
Race/ethnicity
 White482 (25.29)1106 (49.00)1088 (70.15)
 Black51 (2.68)118 (5.23)163 (10.51)
 Asian1277 (67.00)847 (37.53)157 (10.12)
 Hispanic82 (4.30)159 (7.04)104 (6.71)
 Other14 (0.73)27 (1.20)39 (2.51)
Clinical Characteristics
Qualifying stroke neurological severity
 Mild1718 (90.14)2083 (92.29)1457 (93.94)
 Moderate/Severe188 (9.86)174 (7.71)94 (6.06)
Qualifying stroke subtype
 Large vessel atherosclerosis663 (34.78)654 (28.99)388 (25.02)
 Cardioembolic21 (1.10)27 (1.20)20 (1.29)
 Small vessel disease1036 (54.35)1237 (54.83)873 (56.29)
 Other17 (0.89)41 (1.82)45 (2.90)
 Unknown169 (8.87)297 (13.16)225 (14.51)
Baseline systolic blood pressure (median, IQR)142 (130-157)144 (132-158)144 (131-158)
Treatment group
 A †434 (22.90)588 (26.24)367 (23.97)
 B ‡509 (26.86)524 (23.38)377 (24.62)
 C §497 (26.23)583 (26.02)402 (26.26)
 D | |455 (24.01)546 (24.36)385 (25.15)
Risk Factors and Comorbidities
History of previous stroke or TIA
 Yes547 (28.70)621 (27.55)386 (24.89)
History of previous myocardial infarction
 Yes105 (5.51)206 (9.14)178 (11.48)
History of atrial fibrillation
 Yes27 (1.42)34 (1.51)40 (2.58)
History of congestive heart failure
 Yes34 (1.78)52 (2.30)69 (4.45)
History of coronary artery disease
 Yes252 (13.22)433 (19.18)354 (22.82)
History of hypertension
 Yes1481 (77.70)1901 (84.23)1401 (90.33)
History of hyperlipidemia
 Yes882 (46.35)1271 (56.39)959 (61.91)
Smoking status
 Current smoker362 (18.99)427 (18.93)194 (12.52)
Regular alcohol consumption
 ≥ 1 drink/week467 (24.50)696 (30.85)404 (26.06)
Average physical activity prior to qualifying stroke
 Sedentary694 (36.70)896 (39.86)755 (48.96)
 Some physical activity592 (31.31)696 (30.95)456 (29.57)
 Intense physical activity605 (31.99)656 (29.18)331 (21.47)

indicates that 86 participants were excluded due to missing BMI or diabetes information; † indicates Aspirin + Extended Release Dipyridamole/Telmisartan; ‡ indicates Clopidogrel/Telmisartan; § indicates Aspirin + Extended Release Dipyridamole/Placebo; | | indicates Clopidogrel/Placebo.